CLINICAL_TRIALS ClinicalTrials.gov record update

Safety & Efficacy of 68Ga-DOTA-tyr3-Octreotide PET/CT in Diagnosis, Staging & Measurement of Response to Treatment in Patients With Somatostatin Receptor Positive Tumors: Comparison to Octreoscan Plus High-Resolution, Contrast Enhanced CT.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01619865
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:05.080968+00:00
Published At: 2021-02-02T00:00:00+00:00
Record Updated At: 2021-07-27
Results Posted At: 2021-02-02
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Neuroendocrine Tumors", "Carcinoid Tumors", "Neuroblastoma", "Medulloblastoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-07-27"
protocolSection.identificationModule.nctId: "NCT01619865"
protocolSection.identificationModule.officialTitle: "Safety \u0026 Efficacy of 68Ga-DOTA-tyr3-Octreotide PET/CT in Diagnosis, Staging \u0026 Measurement of Response to Treatment in Patients With Somatostatin Receptor Positive Tumors: Comparison to Octreoscan Plus High-Resolution, Contrast Enhanced CT."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2021-02-02"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.